SCHEMBL24501448

SCHEMBL24501448

COC(=O)c1cc2c(cc1Br)ncn2COCC[Si](C)(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 2/20 0.40
LMNA P02545 2/20 0.40
TSHR P16473 1/20 0.40
FGFR1 P11362 2/20 0.37
SRC P12931 1/20 0.37
POLB P06746 2/20 0.35
MAPT P10636 2/20 0.35
KMT2A Q03164 2/20 0.35
MTNR1A P48039 1/20 0.35
MTNR1B P49286 1/20 0.35
BRD4 O60885 2/20 0.35
MEN1 O00255 1/20 0.34
MAPK1 P28482 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HSD17B10 Q99714 1/20 0.34
DGAT1 O75907 2/20 0.33
CREBBP Q92793 1/20 0.32
NPC1 O15118 2/20 0.32
RAB9A P51151 1/20 0.32
ALDH1A1 P00352 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30640065 1.00 USP2 (0.40) USP2LMNATSHRFGFR1SRC
SCHEMBL25727797 0.96 USP2 (0.40) USP2LMNATSHRFGFR1SRC
SCHEMBL26680112 0.84 TSHR (0.40) USP2LMNATSHRFGFR1SRC
SCHEMBL30309791 0.84 TSHR (0.40) USP2LMNATSHRFGFR1SRC
SCHEMBL30309767 0.81 USP2 (0.38) USP2LMNATSHRFGFR1SRC
SCHEMBL29513592 0.80 MEN1 (0.37) FGFR1SRCPOLBMAPTKMT2A
SCHEMBL24344854 0.80 MEN1 (0.37) FGFR1SRCPOLBMAPTKMT2A
SCHEMBL29495175 0.80 TSHR (0.34) USP2LMNATSHRBRD4MAPK1
SCHEMBL25395444 0.80 TSHR (0.34) USP2LMNATSHRBRD4MAPK1
SCHEMBL24344409 0.80 MEN1 (0.45) USP2LMNAPOLBMAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250325552-A1 SUBSTITUTED THIADIAZOLYL DERIVATIVES AS DNA POLYMERASE THETA INHIBITORS IDEAYA BIOSCIENCES INC (US) 2025-10-23 US disclosed
CN-117083271-A Substituted thiadiazolyl derivatives as DNA polymerase theta inhibitors 伊迪亚生物科学有限公司 2023-11-17 CN disclosed
EP-4255573-A1 SUBSTITUTED THIADIAZOLYL DERIVATIVES AS DNA POLYMERASE THETA INHIBITORS Ideaya Biosciences, Inc. (US) 2023-10-11 EP disclosed
WO-2022118210-A1 SUBSTITUTED THIADIAZOLYL DERIVATIVES AS DNA POLYMERASE THETA INHIBITORS IDEAYA BIOSCIENCES, INC. (US) 2022-06-09 WO disclosed
WO-2022118210-A1 SUBSTITUTED THIADIAZOLYL DERIVATIVES AS DNA POLYMERASE THETA INHIBITORS IDEAYA BIOSCIENCES, INC. (US) 2022-06-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250325552-A1 SUBSTITUTED THIADIAZOLYL DERIVATIVES AS DNA POLYMERASE THETA INHIBITORS POLQ, POLK, POLH USP2 2388/4885LMNA 2322/4885TSHR 3796/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.